# Consciousness, Psilocybin, and Well-Being

> **NCT05592379** · PHASE1 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 6 (actual)

## Conditions studied

- Healthy
- Psychedelic Experiences
- Sleep

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Clonidine
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT05592379
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-07
- **Primary completion:** 2025-02-19
- **Final completion:** 2025-02-19
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05592379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05592379, "Consciousness, Psilocybin, and Well-Being". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05592379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*